Insights

  • Date

  • Content Type

  • Reset

Article

Bringing Novel Therapies to Market: 5 Strategies for Success

10.01.22
By Christian K. Schneider, MD

Advanced therapy medicinal products (ATMPs) were making headlines long before SARS-CoV-2, the virus that causes...
Read More

Article

Five marketing strategies for novel therapeutics

8.12.21
By Christian K Schneider

Long before the advent of Coronavirus, next-generation therapies were making headlines, but the successful development of...
Read More

Article

Marketing strategies for next-gen therapies

2.12.21
By Christian K Schneider

The successful development of COVID-19 vaccines, including mRNA vaccines, has shone a spotlight on next-generation therapies...
Read More

Blog

Roadmap to commercialization success: Build agility into drug development plans

29.11.21

By Dr. Diane Seimetz

We know the lifechanging impact that gene, cell and tissue-based therapies..

Read More

Blog

Accelerating commercialization of advanced therapies: it’s time to map a new route to market

26.10.21

By Christian Schneider

For decades, advanced therapies have shown potential to disrupt the $1 trillion global pharmaceuticals...

Read More

Article

Streamlining the Path to Market for Novel Therapies

22.10.21
By Christian K Schneider

Next-generation therapies were already making headlines long before we heard anything about SARS-CoV-2, the virus that...
Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more